Biological and nonbiological complex drugs for multiple sclerosis in Latin America: regulations and risk management.
Carrá A, Macías Islas MA, Tarulla A, Bichuetti DB, Finkelsztejn A, Fragoso YD, Árcega-Revilla R, Cárcamo Rodríguez C, Durán JC, Bonitto JG, León R, Oehninger Gatti C, Orozco G, Vizcarra Escobar D.
Carrá A, et al. Among authors: orozco g.
Expert Rev Neurother. 2015 Jun;15(6):597-600. doi: 10.1586/14737175.2015.1042456. Epub 2015 Apr 30.
Expert Rev Neurother. 2015.
PMID: 25924772